2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Primary Drivers Are Supporting the Continued Market Growth of theGeographic Atrophy Market?

The escalation in the incidence of age-related macular degeneration (AMD) is predicted to fuel the expansion of the geographic atrophy market. AMD is an ocular issue that impairs the center of the retina in older individuals, hindering their ability to discern fine details. The surge in the aging population is the primary catalyst for the rise in AMD cases, as individuals are experiencing longer lifespans, and the normal aging process gradually degrades eye health, increasing their susceptibility to the disease over time. Treatments for geographic atrophy aid AMD patients by decelerating the advancement of retinal degradation and conserving residual vision. For example, in January 2024, per a study shared by Medical News Today, a US digital media establishment, the worldwide count of AMD cases is projected to swell from 196 million to 288 million by 2040. Consequently, the swelling incidence of AMD is the driving force behind the expansion of the geographic atrophy market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21984&type=smp

#What is the Projected CAGR for the Geographic Atrophy Market Size from 2025 to 2034?

In recent times, the market size for geographic atrophy has experienced a swift escalation. The market is projected to experience growth from $1.86 billion in 2024 to $2.12 billion in 2025, registering a compound annual growth rate (CAGR) of 13.7%. This surge over the historic phase can be credited to factors such as the expanding elderly population, increasing demand for potent treatment alternatives, growing incidence of geographic atrophy, heightened health consciousness, and an uptick in the occurrence of retinal diseases.

Over the coming years, the market size for geographic atrophy is anticipated to experience significant expansion. This market is projected to reach $3.50 billion by 2029, growing at a compound annual growth rate (CAGR) of 13.5%. Several factors are anticipated to drive this growth during the forecast period, including an increased emphasis on research and development, a rise in R&D investments, growing smartphone usage, increased spending on healthcare, and heightened investment in clinical trials. The expected trends for this period encompass advancements in gene therapy, improvements in healthcare technology, the introduction of new technologies, the adoption of telemedicine, and the development of innovative and effective drug treatments.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21984

How Are Consumer Market Innovations Shaping the Current and Future Landscape of theGeographic Atrophy Market?

Leading businesses in the geographic atrophy market are concentrating on novel therapies like complement inhibitor therapy to devise superior treatments for geographic atrophy. This regimen works by slowing an overly active immune response associated with some illnesses, safeguarding healthy cells from damage, and minimizing disease progression. For example, Astellas Pharma Inc., a firm based in Japan, announced in February 2025 that the US-based government agency, the Food and Drug Administration, approved their IZERVAY (avacincaptad pegol intravitreal solution) for geographic atrophy treatment. This endorsement permits unlimited duration of IZERVAY administration for the treatment of geographic atrophy (GA) related to age-related macular degeneration (AMD). This verdict gives more management choices for GA, allowing more prolonged treatment possibilities for patients and healthcare providers.

Who Are the Key Market Players Influencing the Growth of the Corn and Geographic Atrophy Industry?

Major companies operating in the geographic atrophy market are Regeneron Pharmaceuticals Inc., Boehringer Ingelheim, Astellas Pharma Inc., Biogen Inc., Ocugen Inc., Kodiak Sciences Inc., Apellis Pharmaceuticals Inc., NGM Biopharmaceuticals Inc., Voyager Therapeutics, Kriya Therapeutics, Stealth BioTherapeutics, Kiora Pharmaceuticals, Iveric Bio, Alkeus Pharmaceuticals, Nanoscope Therapeutics, Graybug Vision, SparingVision, 4D Molecular Therapeutics, Clearside Biomedical, Gensight Biologics

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/geographic-atrophy-global-market-report

Which Key Market Segments Comprise the Geographic Atrophy Market and Drive Its Revenue Growth?

The geographic atrophy market covered in this report is segmented –

1) By Drug Type: Anti-Vascular Endothelial Growth Factor (VEGF) Therapy, Complement Inhibitors, Neuroprotective Agents, Other Drugs

2) By Diagnosis: Fundus Autofluorescence (FAF), Optical Coherence Tomography Angiography (OCT-A), Multifocal Electroretinography (mfERG)

3) By Route Of Administration: Intravitreal, Oral, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

Subsegmentss:

1) By Anti-Vascular Endothelial Growth Factor (VEGF) Therapy: Ranibizumab, Aflibercept, Bevacizumab

2) By Complement Inhibitors: Pegcetacoplan, Lfg316

3) By Neuroprotective Agents: Latanoprost, Brimonidine

4) By Other Drugs: Steroids, Retinoids, Combination Therapy

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=21984&type=smp

Which Regions Are Emerging as Leaders in the Geographic Atrophy Market?

North America was the largest region in the geographic atrophy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the geographic atrophy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Geographic Atrophy Market 2025, By The Business Research Company:

Dry Eye Medication Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dry-eye-medication-market

Elevator And Escalator Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/elevator-and-escalator-market

Eyewear Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/eyewear-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: